UPLC-MS/MS Metabolomics Reveals Babao Dan’s Mechanisms in MASH Treatment with Integrating Network Pharmacology and Molecular Docking
Shijiao Zhang, Yanding Su, Ao Han, He Qi et al. • Pharmaceuticals
(2025)
Background: Metabolic dysfunction-associated steatohepatitis (MASH) is a progressive disease that easily develops into cirrhosis and hepatocellular carcinoma, but its pathogenesis is not clear, and most therapeutic drugs have obvious limita...
DOAJ
Open Access (DOAJ)
DOI:
10.3390/ph18081111